RecruitingPhase 1Phase 2NCT05814640

Sequenced Treatment Alternatives to Relieve Adolescent Depression (STAR-AD)

Sequenced Treatment Alternatives to Relieve Adolescent Depression (STAR-AD): a Pragmatic Clinical Trial


Sponsor

First Affiliated Hospital of Chongqing Medical University

Enrollment

520 participants

Start Date

Feb 20, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

This project aims to investigate the effectiveness of existing common antidepressants and to provide new evidence for depressed children and adolescents who are not responding to their first treatment.


Eligibility

Min Age: 13 YearsMax Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is testing a sequenced treatment approach for teenagers aged 13–18 with moderate-to-severe major depressive disorder (MDD) — trying different therapies in a structured order to find what works best if the first treatment doesn't fully help. **You may be eligible if...** - You are 13–18 years old - You have been diagnosed with major depressive disorder (non-psychotic) according to DSM-5 criteria - Your depression scores are significantly elevated on the standard assessment scale (CDRS-R score of 40 or above) - You and at least one of your parents have given written consent - If you have suicidal thoughts, your doctor believes outpatient treatment is safe for you **You may NOT be eligible if...** - You have a history of bipolar disorder, schizophrenia, autism, or an eating disorder - Your depression involves psychotic features - You are not in the 13–18 age range Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGFluoxetine

Commonly used oral antidepressant.

DRUGSertraline

Commonly used oral antidepressant.

DRUGVortioxetine

Commonly used oral antidepressant.

DRUGDuloxetine

Commonly used oral antidepressant.

DRUGAripiprazole

Commonly used oral augmentation therapy for antidepressants

DRUGLithium Carbonate

Commonly used oral augmentation therapy for antidepressants.

DRUGOlanzapine

Commonly used oral augmentation therapy for antidepressants.

BEHAVIORALGCBT

Commonly used intervention therapy of psychotherapy.


Locations(1)

The First Affiliated Hospital of Chongqing Medical University

Chongqing, Province, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05814640


Related Trials